Interventions for treating microscopic colitis: A cochrane inflammatory bowel disease and functional bowel disorders review group systematic review of randomized trials

American Journal of Gastroenterology

Volumn 104, Issue 1, 2009, Pages 235-241

  Chande, Nilesh ^a,c   MacDonald, John K ^b   McDonald, John W D ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH SALICYLATE; BOSWELLIA SERRATA EXTRACT; BUDESONIDE; COLESTYRAMINE; MESALAZINE; PLACEBO; PREDNISOLONE; PROBIOTIC AGENT; ANTIINFLAMMATORY AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID DERIVATIVE;

ABDOMINAL DISCOMFORT; ABSENCE OF SIDE EFFECTS; BODY WEIGHT; CLINICAL TRIAL; COCHRANE LIBRARY; COLLAGENOUS COLITIS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEADACHE; HISTOLOGY; HUMAN; LEG CRAMP; LYMPHOCYTIC COLITIS; MEDLINE; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; REMISSION; REVIEW; SAMPLE SIZE; SIDE EFFECT; SLEEP DISORDER; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; MICROSCOPIC COLITIS; RANDOMIZED CONTROLLED TRIAL;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUDESONIDE; CHOLESTYRAMINE; COLITIS, MICROSCOPIC; HUMANS; MESALAMINE; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SALICYLATES;

EID: 60749103324     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.16     Document Type: Review

References (28)

1. Chande N, McDonald J, MacDonald J. Interventions for treating collagenous colitis. Cochrane Database Syst Rev 2008;2:CD003575.
2. Chande N, McDonald J, MacDonald J. Interventions for treating lymphocytic colitis. Cochrane Database Syst Rev 2008;2:CD006096.
3. Chande N, McDonald JW, MacDonald JK. Interventions for treating collagenous colitis: a Cochrane Inflammatory Bowel Disease Group systematic review of randomized trials. Am J Gastroenterol 2004;99:2459-65.
4. Jadad A, Moore R, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996:17:1-12.
5. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
6. Eypasch E, Williams JI, Wood-Dauphinee S et al. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg 1995;82:216-22.
7. Irvine EJ, Zhou Q, Thompson AK. The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT investigators. Canadian Crohn's relapse prevention trial. Am J Gastroenterol 1996;91:1571-8.
8. Fine K, Ogunji F, Lee E et al. Randomized, double-blind, placebo-controlled trial of bismuth subsalicylate for microscopic colitis. Gastroenterology 1999;116:A880.
9. Madisch A, Miehlke S, Eichele O et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebocontrolled multicenter trial. Int J Colorectal Dis 2007;22:1445-51.
10. Baert F, Schmit A, D'Haens G et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002;122:20-5.
11. Miehlke S, Heymer P, Bethke B et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002;123:978-84.
12. Bonderup OK, Hansen JB, Birket-Smith L et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003;52:248-51.
13. Madisch A, Heymer P, Voss C et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 2005;20:312-6.
14. Calabrese C, Fabbri A, Areni A et al. Mesalazine with or without cholesty-ramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol 2007;22:809-14.
15. Munck LK, Kjeldsen J, Philipsen E et al. Incomplete remission with shortterm prednisolone treatment in collagenous colitis: a randomized study. Scan J Gastroenterol 2003;38:606-10.
16. Wildt S, Munck LK, Vinter-Jensen L et al. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflamm Bowel Dis 2006;12:395-401.
17. Bonderup O, Hansen J, Teglbjaerg P et al. Long-term budesonide treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gut 2008; July 31 (e-pub ahead of print).
18. Miehlke S, Madisch A, Bethke B et al. Oral budesonide for maintenance treatment of collagenous colitis - a randomized, placebo-controlled, double-blind trial. Gastroenterology 2008 (in press).
19. Miehlke S, Madisch A, Karimi D et al. Budesonide for treatment of lymphocytic colitis - a randomized, double-blind, placebo-controlled trial. United European Gastroenterology Week 2007 MON-G-338.
20. Delarive J, Saraga E, Dorta G et al. Budesonide in the treatment of collagenous colitis. Digestion 1998;59:364-6.
21. Lanyi B, Dries V, Dienes HP et al. Therapy of prednisone- refractory collagenous colitis with budesonide. Int J Colored Dis 1999;14:58-61.
22. Tromm A, Griga T, Mollmann HW et al. Budesonide for the treatment of collagenous colitis: first results of a pilot trial. Am J Gastroenterol 1999;94:1871-5.
23. Mueller-Wittlich I, Boerner NH, Clement TE. Oral budesonide in the treatment of collagenous and microscopic colitis. Gastroenterology 2000;118:A376.
24. Greenberg GR, Feagan BG, Martin F et al. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med 1994;331:836-41.
25. Greenberg GR, Feagan BG, Martin F et al. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 1996;110:45-51.
26. Olesen M, Eriksson S, Bohr J et al. Microscopic colitis: a common diarrhoel disease. An epidemiological study in Orebo, Sweden, 1993-1998. Gut 2004;53:346-50.
27. Wildt S, Nordgaard-Lassen I, Bendten F et al. Metabolic and inflammatory fecal markers in collagenous colitis. Eur J Gastroenterol Hepatol 2007;19:567-74.
28. Tagkalidis P, Gibson P, Bathal P. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol 2007;60:382-7.